Literature DB >> 23546519

Haematological cancer: Lenalidomide improves response.

Bryony Jones.   

Abstract

Entities:  

Year:  2013        PMID： 23546519     DOI： 10.1038/nrclinonc.2013.52

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL).

Authors:  Tait D Shanafelt; Alan G Ramsay; Clive S Zent; Jose F Leis; Han W Tun; Timothy G Call; Betsy LaPlant; Deborah Bowen; Adam Pettinger; Diane F Jelinek; Curtis A Hanson; Neil E Kay
Journal:  Blood       Date:  2013-03-14       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.